4//SEC Filing
Harwin Peter Evan 4
Accession 0001104659-25-061278
CIK 0001974640other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:06 PM ET
Size
12.7 KB
Accession
0001104659-25-061278
Insider Transaction Report
Form 4
Kiselak Tomas
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Peter Harwin)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying) - Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Tomas Kiselak)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying)
Fairmount Funds Management LLC
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Peter Harwin)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying) - Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Tomas Kiselak)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying)
Harwin Peter Evan
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Peter Harwin)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying) - Award
Stock Option (Right to Buy)
2025-06-17+14,461→ 14,461 total(indirect: By: Tomas Kiselak)Exercise: $41.66Exp: 2035-06-17→ Common Stock (14,461 underlying)
Footnotes (3)
- [F1]This option represents the right to purchase 14,461 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.
- [F2]Under Mr. Harwin's arrangement with Fairmount Funds Management LLC ('Fairmount'), Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.
- [F3]Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001663607
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:06 PM ET
- Size
- 12.7 KB